Search research articles
Contact Us
Filters
Showing results (41-50 of 83) with videos related to
Page
of 9
Sort By:
Molecular Therapy. Methods & Clinical Development
|
February 22, 2019
High-Efficiency Lentiviral Transduction of Human CD34<sup>+</sup> Cells in High-Density Culture with Poloxamer and Prostaglandin E2
Naoya Uchida, Tina Nassehi, Claire M Drysdale, et al.
Journal of Virology
|
July 24, 2009
Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells
Naoya Uchida, Kareem N Washington, Jun Hayakawa, et al.
Human Gene Therapy Methods
|
March 8, 2017
RNA Trans-Splicing Targeting Endogenous β-Globin Pre-Messenger RNA in Human Erythroid Cells
Naoya Uchida, Kareem N Washington, Brian Mozer, et al.
Molecular Therapy. Methods & Clinical Development
|
September 22, 2016
Total body irradiation must be delivered at high dose for efficient engraftment and tolerance in a rhesus stem cell gene therapy model
Naoya Uchida, R Patrick Weitzel, Anna Shvygin, et al.
Stem Cell Research & Therapy
|
December 18, 2020
Correction to: Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
Selami Demirci, Juan J Haro-Mora, Alexis Leonard, et al.
Molecular Therapy. Methods & Clinical Development
|
April 5, 2021
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Naoya Uchida, Claire M Drysdale, Tina Nassehi, et al.
Stem Cell Research & Therapy
|
November 25, 2020
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
Selami Demirci, Juan J Haro-Mora, Alexis Leonard, et al.
Nature Communications
|
October 4, 2019
Development of a forward-oriented therapeutic lentiviral vector for hemoglobin disorders
Naoya Uchida, Matthew M Hsieh, Lydia Raines, et al.
Experimental Hematology
|
March 9, 2016
SENP1, but not fetal hemoglobin, differentiates Andean highlanders with chronic mountain sickness from healthy individuals among Andean highlanders
Matthew M Hsieh, David Callacondo, Jose Rojas-Camayo, et al.
Blood Advances
|
May 13, 2020
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease
Matthew M Hsieh, Melissa Bonner, Francis John Pierciey, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 83) with videos related to
Sort By:
Page
of 9
Molecular Therapy. Methods & Clinical Development
|
February 22, 2019
High-Efficiency Lentiviral Transduction of Human CD34<sup>+</sup> Cells in High-Density Culture with Poloxamer and Prostaglandin E2
Naoya Uchida, Tina Nassehi, Claire M Drysdale, et al.
Journal of Virology
|
July 24, 2009
Development of a human immunodeficiency virus type 1-based lentiviral vector that allows efficient transduction of both human and rhesus blood cells
Naoya Uchida, Kareem N Washington, Jun Hayakawa, et al.
Human Gene Therapy Methods
|
March 8, 2017
RNA Trans-Splicing Targeting Endogenous β-Globin Pre-Messenger RNA in Human Erythroid Cells
Naoya Uchida, Kareem N Washington, Brian Mozer, et al.
Molecular Therapy. Methods & Clinical Development
|
September 22, 2016
Total body irradiation must be delivered at high dose for efficient engraftment and tolerance in a rhesus stem cell gene therapy model
Naoya Uchida, R Patrick Weitzel, Anna Shvygin, et al.
Stem Cell Research & Therapy
|
December 18, 2020
Correction to: Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
Selami Demirci, Juan J Haro-Mora, Alexis Leonard, et al.
Molecular Therapy. Methods & Clinical Development
|
April 5, 2021
Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Naoya Uchida, Claire M Drysdale, Tina Nassehi, et al.
Stem Cell Research & Therapy
|
November 25, 2020
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
Selami Demirci, Juan J Haro-Mora, Alexis Leonard, et al.
Nature Communications
|
October 4, 2019
Development of a forward-oriented therapeutic lentiviral vector for hemoglobin disorders
Naoya Uchida, Matthew M Hsieh, Lydia Raines, et al.
Experimental Hematology
|
March 9, 2016
SENP1, but not fetal hemoglobin, differentiates Andean highlanders with chronic mountain sickness from healthy individuals among Andean highlanders
Matthew M Hsieh, David Callacondo, Jose Rojas-Camayo, et al.
Blood Advances
|
May 13, 2020
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease
Matthew M Hsieh, Melissa Bonner, Francis John Pierciey, et al.
Page
of 9